8-K: CleanCore Solutions Settles Key Lawsuits, Issues Equity, and Approves Board and Equity Plan at Annual Meeting

CleanCore Solutions, Inc. announced the settlement of two significant legal disputes with its former CEO and Boustead Securities, involving cash payments and equity issuances, alongside the results of its annual stockholders' meeting where directors were elected and an equity incentive plan amendment was approved.

Summary

• CleanCore Solutions, Inc. (the "Company"), its CEO Clayton Adams, and CFO David Enholm, entered into a settlement and release agreement with Matthew Atkinson, the Company's former Chief Executive Officer, to resolve a lawsuit.
• Pursuant to the Atkinson Settlement Agreement, effective June 21, 2025, the Company agreed to issue 200,000 shares of its Class B common stock to James T. Coyle Legacy Trust to resolve an obligation Mr. Atkinson had to transfer such shares.
• The parties agreed to dismiss the Atkinson Lawsuit with prejudice within five business days of the Effective Date, with each party bearing its own fees and costs.
• The Company also entered into a settlement agreement with Boustead Securities, LLC to resolve compensation claims under prior engagement and underwriting agreements.
• Under the Boustead Settlement Agreement, the Company agreed to pay Boustead $100,000 in cash within 45 days of June 5, 2025.
• On June 9, 2025, the Company issued Boustead warrants for 29,750 shares of Class B common stock at an exercise price of $1.25 per share and warrants for 9,426 shares at an exercise price of $1.06 per share.
• The Company further agreed to pay Boustead an additional $1,050,000 in cash upon the closing of a financing transaction (a "Financing Transaction") of at least $50 million; if less than $50 million, Boustead will receive no less than 2% of the total funds disbursed until $1,050,000 is reached.
• Upon closing a Financing Transaction, the Company will also issue Boustead a warrant for 160,824 shares of Class B common stock at an exercise price equal to the lower of the Financing Transaction price or any placement agent warrant exercise price.
• The Boustead Settlement Agreement will expire one year after June 5, 2025, if the Company fails to execute a term sheet for a Financing Transaction within six months or fails to close the transaction and satisfy the cash/warrant obligations within one year, leading to the reinstatement of original Boustead Agreements.
• At its Annual Meeting of Stockholders on June 5, 2025, with 5,772,452 shares (68% of outstanding Class B common stock) represented, stockholders elected four directors (Clayton Adams, David Enholm, Brent Cox, Peter Frei) to the Board.
• Stockholders ratified the appointment of TAAD, LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2025, with 5,753,636 votes for.
• Stockholders approved Amendment No. 2 to the CleanCore Solutions, Inc. 2022 Equity Incentive Plan to increase the share reserve, with 4,776,083 votes for.

Sentiment

Score: 6

Explanation: The resolution of two legal disputes is positive, removing uncertainty and potential liabilities. However, the settlements involve significant dilution through share and warrant issuances, and a substantial contingent cash payment. The reliance on a future $50M financing transaction for the full resolution of the Boustead agreement introduces a notable risk and contingency. The annual meeting results are routine and positive for corporate governance.

Positives

• Resolution of two significant legal disputes (with former CEO Matthew Atkinson and Boustead Securities) reduces legal uncertainty and potential ongoing litigation costs.
• The Board of Directors determined that settling the lawsuit with Matthew Atkinson was in the best interests of the Company and its stockholders.
• Successful election of all four nominated directors and ratification of the independent public accounting firm at the annual meeting demonstrates stable corporate governance.
• Approval of Amendment No. 2 to the 2022 Equity Incentive Plan increases the share reserve, providing the Company with greater flexibility for future equity-based compensation and incentive programs.

Negatives

• The settlement with Matthew Atkinson involves the issuance of 200,000 shares of Class B common stock, which will result in dilution for existing shareholders.
• The settlement with Boustead Securities requires an immediate cash payment of $100,000 and the issuance of 39,176 warrants (29,750 at $1.25 and 9,426 at $1.06), leading to immediate financial outflow and potential future dilution.
• A significant contingent cash payment of $1,050,000 and the issuance of 160,824 additional warrants are tied to a future Financing Transaction, adding a substantial financial obligation.
• Failure to secure a Financing Transaction of at least $50 million within one year will result in the expiration of the Boustead Settlement Agreement and the reinstatement of prior, potentially more onerous, obligations including a right of first refusal.

Risks

• Dilution Risk: The issuance of 200,000 shares for the Atkinson settlement and the current/future warrants to Boustead Securities will dilute the ownership stake of existing shareholders.
• Financing Risk: The full resolution of the Boustead settlement and termination of prior agreements are contingent on the Company successfully closing a Financing Transaction of at least $50 million within one year (by June 5, 2026). Failure to secure this financing could lead to the reinstatement of original Boustead Agreements, including a right of first refusal, potentially hindering future capital raises.
• Cash Flow Risk: The Company is obligated to make a $100,000 cash payment to Boustead within 45 days and a potential $1,050,000 payment upon a Financing Transaction, which could strain liquidity if the financing is delayed or smaller than anticipated.
• Legal Risk (Reinstatement): If the Financing Transaction deadlines are not met, the original Boustead Agreements and associated obligations will be reinstated, potentially leading to renewed disputes or financial burdens.

Future Outlook

The Company is actively pursuing a "Financing Transaction" of at least $50 million, which is crucial for fully satisfying the Boustead settlement and terminating prior agreements. Failure to secure this financing within one year will result in the reinstatement of previous obligations, including a right of first refusal, potentially impacting future capital raising efforts.

Management Comments

• "The Board of Directors of the Company determined that resolving the Lawsuit in exchange for the Shares was in the best interests of the Company and its stockholders." (Regarding Atkinson settlement)
• "Plaintiff knowingly, freely, and voluntarily agrees to all of the terms and conditions set out in this Agreement including, without limitation, the waiver, release, and covenants contained in it." (Regarding Atkinson settlement)
• "The Parties agree that no Party shall seek to frustrate, impede or interfere with the fulfillment of the terms of this Settlement Agreement by any other Party." (Regarding Boustead settlement)

Industry Context

N/A

Corporate Governance

Legal Proceedings

• Lawsuit filed by Matthew Atkinson (former CEO) against the Company, CEO Clayton Adams, and CFO David Enholm in the District Court of Douglas County, Nebraska, alleging claims including Nebraska Wage Payment and Collection Act violations, breach of employment/separation agreements, breach of good faith/fair dealing, promissory estoppel, and fraudulent inducement. The Company alleged counterclaims for breach of contract. This lawsuit has been settled and will be dismissed with prejudice.
• Dispute with Boustead Securities, LLC regarding compensation owed under an Engagement Letter (September 21, 2022) and an Underwriting Agreement (April 25, 2024), including compensation related to the Sanzonate Transaction (April 15, 2025) and Note Transaction (April 16, 2025). This dispute has been settled via the Boustead Settlement Agreement.

Related Party Transactions

• Settlement Agreement with Matthew Atkinson, the Company's former Chief Executive Officer, involving the issuance of 200,000 shares of Class B common stock to James T. Coyle Legacy Trust to resolve an obligation Mr. Atkinson had to transfer such shares.

Stakeholder Impact

• Shareholders: Will experience dilution from the issuance of 200,000 shares for the Atkinson settlement and potential 199,990 warrants issued to Boustead. However, they benefit from the resolution of legal uncertainties and potential ongoing litigation costs. The approval of the equity incentive plan could impact future dilution but also aligns management incentives.
• Former CEO (Matthew Atkinson): Benefits from the resolution of his lawsuit against the Company and the Company assuming his obligation to transfer 200,000 shares to James T. Coyle Legacy Trust.
• Boustead Securities, LLC: Receives cash payments and warrants, resolving its compensation claims and potentially terminating prior agreements.
• Management (Clayton Adams, David Enholm): Were defendants in the Atkinson lawsuit, which is now settled, removing personal legal exposure. The equity incentive plan approval provides flexibility for future compensation.

Next Steps

• CleanCore Solutions, Inc. to issue 200,000 shares of Class B common stock to James T. Coyle Legacy Trust on June 21, 2025.
• Parties to the Atkinson Lawsuit to dismiss the lawsuit with prejudice within five business days of June 21, 2025.
• CleanCore to pay Boustead Securities $100,000 in cash within 45 days of June 5, 2025.
• CleanCore to pursue a "Financing Transaction" of at least $50 million.
• Upon closing of a Financing Transaction, CleanCore to pay Boustead an additional $1,050,000 (or 2% of funds if less than $50M) and issue 160,824 Transaction Warrants.
• CleanCore must execute a term sheet or letter of intent for a Financing Transaction within six months of June 5, 2025.
• CleanCore must close a Financing Transaction and satisfy Boustead payment/warrant obligations within one year of June 5, 2025.

Key Dates

Recommendation

Keywords

CleanCore Solutions, SEC filing, 8-K, settlement agreement, Matthew Atkinson, Boustead Securities, legal dispute, equity issuance, common stock, warrants, annual meeting, corporate governance, shareholder vote, equity incentive plan, dilution, capital raise, financing transaction, ZONE, NYSE American